Overview

Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects

Status:
Completed
Trial end date:
2021-04-16
Target enrollment:
Participant gender:
Summary
A Non-Randomized, Open-Label, Drug-Drug Interaction Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics and Safety of EDP-938 in Healthy Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Enanta Pharmaceuticals
Treatments:
Fluconazole